Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Innocan Pharma submits Investigational New Animal Drug application to FDA's Veterinary Center.

and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan has established a Joint Venture by the name of BI Sky Global Ltd. For more information please visit, https://innocanpharma.com/

Cytonics Begins First-In-Human Phase 1 Clinical Study for CYT-108 in Osteoarthritis Knee Patients

activity against the major classes of proteases that are responsible for the majority of cartilage catabolism in arthritic joints, while maintaining its broad-spectrum anti-protease activity against serine and threonine proteases. "Our...

BARDA and Tiba Biotech Collaborate to Develop Next-Gen Influenza Therapeutics

the Collaborative Influenza Vaccine Innovation Centers (CIVICs). Tiba was also recently accepted into BLUE KNIGHT ™, a joint initiative between Johnson & Johnson Innovation – JLABS ('JLABS') and BARDA, with an aim to harness innovation to combat...

Leqembi Secures Approval for Alzheimer's Disease Treatment in Hong Kong

Leqembi in the Nordic region, pending European approval, and currently Eisai and BioArctic are preparing for a joint commercialization in the region. About lecanemab (generic name, brand name: Leqembi®): Lecanemab (Leqembi) is the result of a...

FDA Accepts sBLA Filing of Leqembi® (lecanemab-irmb) for IV Maintenance Dosing in Early Alzheimer's Treatment

lecanemab in the Nordic region, pending European approval, and currently Eisai and BioArctic are preparing for a joint commercialization in the region. About lecanemab (generic name, U.S., Japan and China brand name: Leqembi®) Lecanemab (Leqembi)...

Tempo Therapeutics Appoints Eric I. Richman to Board of Directors

medicine, today announced the addition of Eric I. Richman, MBA to its board of directors. "We are delighted to have Eric join the board at Tempo. His extensive strategic and operational experience paired with his proven track record of success in...

Orthofix Receives FDA 510(k) Clearance for Rodeo™ Telescopic Nail

Europe, and we are pleased to be able to announce this limited U.S. market release during National OI Awareness Week and join in educating others about this genetic bone disorder that is present at birth.” Often referred to as brittle bone disease,...

Tentarix Biotherapeutics announces appointment of Andrew D. Kidd, MD, CFA, as CEO

Tentarix Biotherapeutics announced the appointment of Andrew Kidd, MD, as chief executive officer. Mr. Kidd joins Tentarix with a distinguished career of over two decades of executive and biotech experience. He was most recently the president and...

Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System

and function of hyaline cartilage, the strong and flexible tissue that enables the smooth and pain-free movement of your joints. By incorporating components that provide both strength and lubrication, HYALEX Cartilage is designed to replace painful...

Psilera Welcomes Biopharma Executive Dr. Magali Haas to its Board of Directors

focused on operationalizing brain health through the development, validation and adoption of a global brain health index. "Joining the board of Psilera provides a thrilling opportunity to be at the forefront of brain health research," said Dr....

SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine

facilities to ensure adherence to Good Manufacturing Practices (GMP) and quality control standards. SKYTyphoid was jointly developed with the International Vaccine Institute (IVI) and is supported by the Bill & Melinda Gates Foundation. This...

CVS Pharmacy® announces new simplified loyalty experience

said Zach Dennett, Vice President of Loyalty, Omnichannel and Hispanic Formats, CVS Health. "Now, instead of having to join various programs to unlock all the savings available to them, we've made it easier for our members and patients to choose...

About Us | Pharmaceutical-Era.com - Leading B2B Media for the Pharmaceutical Industry

looking to enhance visibility and reach, Pharmaceutical Era is your gateway to the pulse of the pharmaceutical world. Join us on this exciting journey of discovery, innovation, and collaboration. Explore Pharmaceutical Era today and unlock a world...

Results 121 - 133 of 133